title: Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis.
abstract: A large proportion of urinary stones have calcium oxalate (CaOx) as the major mineral phase. In these stones, CaOx is generally associated with minor amounts of other calcium salts. Several reports showing the presence of calcium carbonate (CaCO3) and calcium phosphate in renal stones suggested that crystals of those salts might be present in the early steps of stone formation. Such crystals might therefore promote CaOx crystallization from supersaturated urine by providing an appropriate substrate for heterogeneous nucleation. That possibility was investigated by seeding a metastable solution of 45Ca oxalate with vaterite or calcite crystallites. Accretion of CaOx was monitored by 45Ca incorporation. We showed that (1) seeds of vaterite (the hexagonal polymorph of CaCO3) and calcite (the rhomboedric form) could initiate calcium oxalate crystal growth; (2) in the presence of lithostathine, an inhibitor of CaCO3 crystal growth, such accretion was not observed. In addition, scanning electron microscopy demonstrated that growth occurred by epitaxy onto calcite seeds whereas no special orientation was observed onto vaterite. It was concluded that calcium carbonate crystals promote crystallization of calcium oxalate and that inhibitors controlling calcium carbonate crystal formation in Henle's loop might play an important role in the prevention of calcium oxalate stone formation.
authors.affiliation: Unité de Recherches de Physiologie et Pathologie Digestives, INSERM U315, 46, Boulevard de la Gaye 13009 Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Geider
authors.forename: B
authors.initials: B
authors.lastname: Dussol
authors.forename: S
authors.initials: S
authors.lastname: Nitsche
authors.forename: S
authors.initials: S
authors.lastname: Veesler
authors.forename: P
authors.initials: P
authors.lastname: Berthézène
authors.forename: P
authors.initials: P
authors.lastname: Dupuy
authors.forename: J P
authors.initials: JP
authors.lastname: Astier
authors.forename: R
authors.initials: R
authors.lastname: Boistelle
authors.forename: Y
authors.initials: Y
authors.lastname: Berland
authors.forename: J C
authors.initials: JC
authors.lastname: Dagorn
authors.forename: J M
authors.initials: JM
authors.lastname: Verdier
mesh_terms: D002119:Calcium Carbonate / Q000737:chemistry*; D002129:Calcium Oxalate / Q000737:chemistry*; D002135:Calcium-Binding Proteins / Q000737:chemistry; D003460:Crystallization; D018360:Crystallography, X-Ray; D006801:Humans; D051847:Lithostathine; D017348:Microscopy, Electron, Scanning Transmission; D009419:Nerve Tissue Proteins; D014545:Urinary Calculi / Q000209:etiology
chemical_list: D002135:Calcium-Binding Proteins; D051847:Lithostathine; D009419:Nerve Tissue Proteins; C497617:REG1A protein, human; D002129:Calcium Oxalate; D002119:Calcium Carbonate